Educational Objectives

 Provide an explanation for the mechanisms behind the formation of
 small dense LDL and HDL.

 Interpret the different methods of LDL and HDL subfraction testing.

 Describe the effects of non-pharmacological and drug treatment
 of LDL and HDL subfractions.

 Recognize the role of inflammatory markers, hs-CRP, Lp-PLA2 and
 myleoperoxidase in assessing cardiovascular risk and
 modifying therapeutic approaches.

 Explain the role of non-invasive measures of atherosclerosis
 in clinical care.

 Interpret carotid IMT and 64-slice CT and the management of
 cardiovascular risk.

This edition is for information and study purposes only as the CME credits have expired.

Back to Complex Lipid Management